ArticleRespirology case reports2021

Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.

Nophol Leelayuwatanakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.